In memoriam: Ludwig G. Strauss, MD, 1949–2013 Antonia Dimitrakopoulou-StraussIgnasi Carrió Obituary 07 June 2013 Pages: 1299 - 1300
PET/CT and breast cancer subtypes Laura GilardiMarco ColleoniGiovanni Paganelli Editorial Commentary 08 June 2013 Pages: 1301 - 1303
Molecular subtypes of breast cancer: metabolic correlation with 18F-FDG PET/CT Ana María García VicenteÁngel Soriano CastrejónAna González Ageitos Original Article 30 April 2013 Pages: 1304 - 1311
An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax Emmanuel IttiMichel MeignanCorinne Haioun Original Article 07 May 2013 Pages: 1312 - 1320
Prognostic value of whole-body metabolic tumour volume and total lesion glycolysis measured on 18F-FDG PET/CT in patients with extranodal NK/T-cell lymphoma Choon-Young KimChae Moon HongByeong-Cheol Ahn Original Article 15 May 2013 Pages: 1321 - 1329
High FDG activity in focal fat necrosis: a pitfall in interpretation of posttreatment PET/CT in patients with non-Hodgkin lymphoma Raghava KashyapEddie LauMichael S. Hofman Original Article 08 May 2013 Pages: 1330 - 1336
Imaging characteristics of cardiac dominant diffuse large B-cell lymphoma demonstrated with MDCT and PET/CT Yasuka KikuchiNoriko Oyama-ManabeHiroki Shirato Original Article 08 May 2013 Pages: 1337 - 1344
The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3) Odré PaliePierre MichelPierre Vera Original Article 29 May 2013 Pages: 1345 - 1355
Role of 18F-choline PET/CT in suspicion of relapse following definitive radiotherapy for prostate cancer Sotirios ChondrogiannisMaria Cristina MarzolaDomenico Rubello Original Article 14 May 2013 Pages: 1356 - 1364
68Ga-DOTA0-Tyr3-octreotide positron emission tomography in head and neck squamous cell carcinoma Volker H. SchartingerJózsef DudásDaniel Putzer Original Article 18 May 2013 Pages: 1365 - 1372
Pretargeted radioimmunotherapy: clinically more efficient than conventional radioimmunotherapy? Caroline RousseauFrançoise Kraeber-BodéréJean-François Chatal Editorial Commentary 13 June 2013 Pages: 1373 - 1376
Pretargeted immuno-PET and radioimmunotherapy of prostate cancer with an anti-TROP-2 x anti-HSG bispecific antibody Catharina M. van RijSusanne LütjeOtto C. Boerman Original Article 15 May 2013 Pages: 1377 - 1383
Phase I pharmacokinetic and biodistribution study with escalating doses of 223Ra-dichloride in men with castration-resistant metastatic prostate cancer Jorge A. CarrasquilloJoseph A. O’DonoghueMichael J. Morris Original Article 08 May 2013 Pages: 1384 - 1393
Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer’s disease dementia Javier ArbizuE. Prietofor the Alzheimer’s Disease Neuroimaging Initiative Original Article 29 May 2013 Pages: 1394 - 1405
[11C]-(R)PK11195 tracer kinetics in the brain of glioma patients and a comparison of two referencing approaches Zhangjie SuKarl HerholzRainer Hinz Original Article Open access 29 May 2013 Pages: 1406 - 1419
18F-FDG PET/CT in HIV-related central nervous system pathology Scarlett LewitschnigKeerti GedelaGary J. R. Cook Original Article 18 May 2013 Pages: 1420 - 1427
Perfusion SPECT in patients with suspected pulmonary embolism: how much sensitivity is needed to keep patients alive? Carl Schuemichen Editorial 08 June 2013 Pages: 1428 - 1431
Perfusion SPECT in patients with suspected pulmonary embolism Marika BajcMassimo MiniatiPaul D. Stein Original Article 08 May 2013 Pages: 1432 - 1437
Highlights of the 25th Anniversary EANM Congress Milan 2012: nuclear medicine and molecular imaging at its best Werner LangstegerMohsen Beheshti Review Article 06 August 2013 Pages: 1438 - 1461
RETRACTED ARTICLE: Neuroradiological advances detect abnormal neuroanatomy underlying neuropsychological impairments: the power of PET imaging Benjamin Jacob HayempourAbass Alavi Review Article 11 April 2013 Pages: 1462 - 1468
Reply to: Area under the cumulative SUV-volume histogram is not a viable metric of intratumoral metabolic heterogeneity Floris H. P. van VeldenRonald Boellaard Letter to the Editor 11 June 2013 Pages: 1469 - 1470
The value of renal scintigraphy in the diagnosis of intrarenal urinoma Hamid JavadiMajid Assadi Image of the Month 19 April 2013 Pages: 1471 - 1472